Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aurobindo Pharma: Execution Of Master Service Agreement Between Merck Sharpe & Dohme Singapore Trading Pte. Ltd. (MSD) And Theranym Biologics Private Limited A Wholly Owned Subsidiary
News Announcement

Aurobindo Pharma: Execution Of Master Service Agreement Between Merck Sharpe & Dohme Singapore Trading Pte. Ltd. (MSD) And Theranym Biologics Private Limited A Wholly Owned Subsidiary

31-May-2024 Follow Value Research Online on Google download pdfDownload PDF Aurobindo Pharma

Intimation of execution of Master Service Agreement signed between Merck Sharpe & Dohme Singapore Trading Pte. Ltd and TheraNym Biologics Private Limited a wholly owned subsidiary of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.